Bybit Web3 Transforms into Bybit Alpha, A One-Click Smart Gateway to On-Chain Opportunities
DUBAI, UAE, Oct. 20, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency…
Rapid7 Celebrates 7th Year of Recognition in Gartner Magic Quadrant for Security Information and Event Management (SIEM)
BOSTON, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Rapid7, Inc. (NASDAQ: RPD), a…
The 138th Canton Fair is Set to Open in Guangzhou on October 15
GUANGZHOU, China, Oct. 13, 2025 /PRNewswire/ -- The 138th China Import and…
RMC Switchgears Limited Reports Q1 FY2025-26 PBT of 12.44 Crore, Maintains Strong Growth Momentum
JAIPUR, India, Sept. 19, 2025 /PRNewswire/ -- In a continuous endeavour to…
Huawei Cloud: Empowering Customers to Succeed in Global Markets Through Continuous Innovation
SHANGHAI, Sept. 19, 2025 /PRNewswire/ -- At HUAWEI CONNECT 2025, Charles Yang,…
HTX Tops Global Metrics, Marking a Triumphant Return After 12 Years
PANAMA CITY, Aug. 27, 2025 /PRNewswire/ --Â HTX, one of the leading global…
Cisco Receives Frost & Sullivan’s 2025 Global Company of the Year Recognition for Leadership in Mobile IoT Platforms
Acknowledged for driving continuous innovation and delivering flexible, scalable solutions that enable…
PartnerOne Acquires Workforce Tech Leader Monster Government Solutions
RIVERSIDE, Calif., Aug. 7, 2025 /PRNewswire/ -- PartnerOne, one of the fastest…
GlucoModicum Reports Positive Clinical Results with its Needle-Free CGM and Advances Toward Market Launch
GlucoModicum Reports Positive Clinical Results with its Needle-Free CGM and Advances Toward…
Novo Nordisk A/S: Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with haemophilia A in new phase 3 data presented at the ISTH 2025 Congress
New FRONTIER5 data show that a direct switch to investigational Mim8 (denecimig)…